BACLOFEN TABLET
Země: Kanada
Jazyk: angličtina
Zdroj: Health Canada
Charakteristika produktu
(SPC)
20-08-2014
Některé dokumenty pro tento produkt momentálně nejsou k dispozici, můžete poslat požadavek našemu zákaznickému servisu a my vás upozorníme, jakmile je dokážeme získat.
Poslat žádost.
Poslat žádost.
Aktivní složka:
BACLOFEN
Dostupné s:
APOTEX INC
ATC kód:
M03BX01
INN (Mezinárodní Name):
BACLOFEN
Dávkování:
10MG
Léková forma:
TABLET
Složení:
BACLOFEN 10MG
Podání:
ORAL
Jednotky v balení:
100/250/500/1000
Druh předpisu:
Prescription
Terapeutické oblasti:
GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS
Přehled produktů:
Active ingredient group (AIG) number: 0113246001; AHFS:
Stav Autorizace:
CANCELLED POST MARKET
Datum autorizace:
2014-08-23
Charakteristika produktu
Page 1 of 27
PRODUCT MONOGRAPH
BACLOFEN
BACLOFEN TABLETS USP
10 MG AND 20 MG
ANTISPASTIC AGENT
APOTEX INC. DATE OF PREPARATION:
150 SIGNET DRIVE August 18, 2014
TORONTO, ONTARIO
M9L 1T9
Control Number: 176430
Page 2 of 27
TABLE OF CONTENT
THERAPEUTIC CLASSIFICATION
...............................................................................................
3
CLINICAL PHARMACOLOGY
......................................................................................................
3
INDICATIONS
..................................................................................................................................
5
CONTRAINDICATIONS
.................................................................................................................
5
WARNINGS
......................................................................................................................................
5
PRECAUTIONS
................................................................................................................................
7
ADVERSE REACTIONS
................................................................................................................
10
SYMPTOMS AND TREATMENT OF OVERDOSAGE
.............................................................. 13
DOSAGE AND ADMINISTRATION
............................................................................................
14
AVAILABILITY
.............................................................................................................................
15
CHEMISTRY AND PHARMACOLOGY
......................................................................................
17
TOXICOLOGY
...............................................................................................................................
18
TERATOLOGY AND REPRODUCTION STUDIES
....................................................................
20
SELECTED BIBLIOGRAPHY
...................................................................................................
Přečtěte si celý dokument
